Non-invasive Coronary Imaging Market Size & Growth Forecast 2026–2035, By Segments (End-use, Modality), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Non-invasive Coronary Imaging Market size was more than USD 422.35 Million in 2025 and is set to grow at a 6.7% CAGR between 2026 and 2035, surpassing USD 807.82 Million by 2035. The industry revenue for 2026 is assessed at USD 447.06 million.
Get more details on this report
Request Free Sample ReportNon-invasive Coronary Imaging Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 40.28% of the market in 2025, supported by advanced imaging infrastructure, routine cardiovascular assessments, high equipment utilization, and established clinical adoption across healthcare settings.
- Asia Pacific is projected to grow at a 7.57% CAGR, driven by expanding healthcare infrastructure, wider adoption of advanced cardiac diagnostics, and increasing demand for scalable coronary evaluation services.
Segment Momentum
- Hospitals accounted for 45.16% of the market in 2025 because cardiac imaging is integrated into routine diagnostics, emergency care, cardiology services, and comprehensive patient management workflows.
- Radionuclide cardiac imaging is the fastest-growing modality due to increasing demand for myocardial perfusion assessment and more targeted physiological evaluation in complex coronary diagnostic pathways.
Market Expansion Drivers
- Rising cardiovascular disease prevalence and aging population driving non-invasive diagnostic demand.
- AI-powered imaging and high-resolution diagnostics improving coronary disease detection accuracy.
- Expanding insurance reimbursement coverage increasing accessibility of advanced cardiac imaging procedures.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Leading companies in the non-invasive coronary imaging market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Fujifilm Holdings Corporation (Japan), United Imaging Healthcare Co., Ltd. (China), Shimadzu Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Esaote S.p.A. (Italy), Samsung Medison Co., Ltd. (South Korea).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As cardiovascular disease becomes more common and patient populations skew older, providers are seeing a larger volume of individuals requiring earlier and more frequent coronary assessment, which is increasing demand for the non-invasive coronary imaging market. Clinicians are increasingly prioritizing imaging pathways that can evaluate suspected coronary artery disease without the procedural risks, recovery burden, and hospital resource use associated with invasive testing, especially for elderly patients with multiple comorbidities. This shift supports market expansion by increasing utilization of CT coronary angiography, cardiac MRI, and related modalities as front-line tools in triage, risk stratification, and follow-up care.
AI-powered imaging and high-resolution diagnostics improving coronary disease detection accuracy
Advances in AI-assisted image reconstruction, automated interpretation, and higher-resolution imaging are driving market development by making coronary assessment more clinically actionable and operationally efficient. In the non-invasive coronary imaging market, improved image quality and algorithm-supported analysis help clinicians detect stenosis, plaque characteristics, and other subtle coronary findings with greater confidence, reducing uncertainty in borderline cases and supporting broader adoption in routine cardiology workflows. These capabilities also help imaging centers manage rising scan volumes by shortening review times and standardizing interpretation, which reinforces market demand among hospitals seeking both diagnostic precision and productivity gains.
Expanding insurance reimbursement coverage increasing accessibility of advanced cardiac imaging procedures
Broader reimbursement for advanced cardiac imaging changes referral behavior by reducing the out-of-pocket barrier that often delays or limits diagnostic follow-through, increasing market penetration for the non-invasive coronary imaging market. When payers recognize more procedures and indications, hospitals and outpatient centers are more willing to invest in imaging capacity, while cardiologists gain stronger justification for recommending non-invasive tests earlier in the diagnostic pathway. The practical effect is a wider addressable patient base and more consistent procedure volumes, particularly for modalities that previously faced adoption constraints tied less to clinical value than to payment uncertainty.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cardiovascular disease prevalence and aging population driving non-invasive diagnostic demand | 2.60% | High | North America, Europe, Asia Pacific | High | Near Term |
| AI-powered imaging and high-resolution diagnostics improving coronary disease detection accuracy | 2.30% | High | North America, Europe, Asia Pacific | Medium | Mid Term |
| Expanding insurance reimbursement coverage increasing accessibility of advanced cardiac imaging procedures | 2.10% | High | North America, Europe | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 40.28% share of the non-invasive coronary imaging market in 2025, bolstered by established diagnostic pathways, broad access to advanced imaging systems, and a high volume of cardiovascular evaluations across hospital and outpatient settings. The region’s leadership is underpinned by routine use of imaging in the assessment of chest pain, coronary artery disease risk, and treatment planning, which keeps equipment utilization high and supports steady replacement and upgrade demand. Strong clinical familiarity with non-invasive modalities also helps embed these technologies into everyday cardiology workflows rather than limiting them to selective use.
Asia Pacific is projected to expand at a 7.57% CAGR over the forecast period, with growth in the non-invasive coronary imaging market being propelled by wider healthcare infrastructure development and rising adoption of advanced cardiac diagnostics in large patient populations. Demand is accelerating as providers increase access to earlier cardiovascular assessment and expand imaging capacity beyond top-tier urban centers, bringing these tools into more routine clinical practice. The region’s momentum is also tied to the practical need for scalable diagnostic approaches that can support growing volumes of patients requiring timely coronary evaluation.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Imaging PrecisionGermany prioritizes non-invasive coronary imaging systems that deliver high-resolution visualization and standardized diagnostic performance. Healthcare institutions in Germany invest in technology upgrades that support efficient cardiovascular assessment and evidence-based clinical practice.
France 🇫🇷
Integrated Cardiac DiagnosticsFrance supports non-invasive coronary imaging through coordinated cardiovascular care and continued modernization of diagnostic capabilities. Healthcare providers in France focus on improving imaging efficiency while expanding access to advanced cardiac assessment technologies.
Italy 🇮🇹
Hospital Imaging ModernizationItaly continues strengthening non-invasive coronary imaging through modernization of hospital imaging capabilities and broader adoption of advanced diagnostic systems. Medical centers in Italy prioritize reliable imaging performance and efficient cardiovascular evaluation within routine clinical practice.
Japan 🇯🇵
High-Resolution Imaging FocusJapan emphasizes non-invasive coronary imaging solutions capable of delivering precise cardiovascular visualization with efficient patient workflows. Medical providers in Japan continue adopting advanced imaging technologies that support early assessment and optimized diagnostic decision-making.
South Korea 🇰🇷
Digital Cardiology AdoptionSouth Korea integrates non-invasive coronary imaging with digitally connected healthcare infrastructure and advanced diagnostic practices. Hospitals in South Korea emphasize efficient imaging workflows and technology-enabled cardiovascular evaluation to enhance patient management.
United States 🇺🇸
Advanced Diagnostic IntegrationThe U.S. non-invasive coronary imaging market emphasizes advanced imaging technologies that improve diagnostic accuracy and clinical workflow efficiency. Healthcare providers in the U.S. continue integrating AI-assisted interpretation and modern imaging platforms into cardiovascular care pathways.
Segment Leadership and Growth Trends
Non-invasive Coronary Imaging Market Share (%), End-use, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportHospitals held the strongest position in the non-invasive coronary imaging market in 2025, accounting for a 45.16% share. Their leadership is maintained through the routine concentration of cardiac diagnostics within hospital settings, where imaging is closely integrated with emergency care, cardiology departments, and broader patient management workflows. Hospitals also remain the primary point of access for patients requiring comprehensive cardiovascular assessment, which supports steady utilization of non-invasive coronary imaging across both acute and scheduled care pathways.
Research Institute is emerging as the fastest-growing end-use segment in the non-invasive coronary imaging market as demand rises for advanced imaging applications in cardiovascular research and clinical investigation. Growth in this segment is being reinforced through the increasing use of imaging tools to study coronary disease mechanisms, validate diagnostic approaches, and support evidence generation in structured research environments. Compared with conventional care settings, research institutes are gaining momentum because their imaging adoption is tied more directly to expanding investigational activity and specialized study requirements.
Modality Segment Analysis: Echocardiography (Largest Segment) vs Radionuclide Cardiac Imaging (Fastest-Growing Segment)
By 2025, Echocardiography captured a 35.09% share of the non-invasive coronary imaging market, making it the largest modality segment. Its continued dominance reflects its established role in frontline cardiac assessment, where it is widely used for rapid, non-invasive evaluation within routine clinical practice. The segment’s leadership is reinforced by its broad availability across care settings and its practical fit for repeated cardiovascular imaging, making echocardiography a standard modality in day-to-day coronary assessment workflows.
Radionuclide Cardiac Imaging represents the fastest-growing modality in the non-invasive coronary imaging market, influenced by rising demand for more function-focused assessment of coronary conditions. Its growth momentum comes from its utility in evaluating myocardial perfusion and supporting more targeted diagnostic interpretation when standard imaging pathways require deeper physiological insight. Relative to more established modalities, radionuclide cardiac imaging is seeing wider adoption because it addresses specific clinical needs in coronary evaluation that are increasingly relevant in more complex diagnostic scenarios.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Diagnostic Imaging Centers, Research Institute | Hospitals | Research Institute |
| Modality | Radionuclide Cardiac Imaging, Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging | Echocardiography | Radionuclide Cardiac Imaging |
Competitive Landscape and Market Positioning
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. Fujifilm Holdings Corporation (Japan)
6. United Imaging Healthcare Co. Ltd. (China)
7. Shimadzu Corporation (Japan)
8. Neusoft Medical Systems Co. Ltd. (China)
9. Esaote S.p.A. (Italy)
10. Samsung Medison Co. Ltd. (South Korea)
The non-invasive coronary imaging market is progressing through innovations that enhance imaging precision and early cardiovascular disease detection. Research activities focused on faster scanning technologies and improved diagnostic accuracy are supporting greater adoption across modern healthcare settings.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Philips | Feb-24 | Philips launched the CT 5300 system, an advanced X-ray CT platform integrated with AI-driven diagnostic and workflow tools. Designed for high-throughput environments, the system enhances diagnostic precision and system uptime for cardiovascular imaging, streamlining clinical procedures and reducing operational bottlenecks in radiology and interventional departments through automated image reconstruction and dose management. |
| Shanghai United Imaging Healthcare | Jul-24 | Shanghai United Imaging Healthcare (UIH) completed the installation of its first PET/CT scanner at the Instituto Nacional de Pediatría in Mexico. This deployment represents a strategic geographic expansion into the Latin American medical imaging market, establishing a local clinical footprint for UIH’s high-end molecular imaging technology and enhancing regional access to advanced, non-invasive diagnostic capabilities for pediatric oncology and cardiovascular assessment. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Non-invasive Coronary Imaging Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Non-invasive Coronary Imaging Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow big is the non-invasive coronary imaging market?
What is the expected industry size of non-invasive coronary imaging by 2035?
How is the need for earlier cardiac assessment driving adoption of non-invasive coronary imaging?
How are AI capabilities improving operational adoption of non-invasive coronary imaging technologies?
Why are hospitals the largest end-use segment in the non-invasive coronary imaging market?
What is driving growth in radionuclide cardiac imaging within the non-invasive coronary imaging market?
Why is North America the largest market for non-invasive coronary imaging?
What factors are accelerating the non-invasive coronary imaging market in Asia Pacific?
Who are the major participants shaping the non-invasive coronary imaging landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization